Rasika Mathias
Concepts (743)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Genome-Wide Association Study | 88 | 2025 | 1337 | 5.230 |
Why?
| Polymorphism, Single Nucleotide | 101 | 2025 | 2065 | 4.660 |
Why?
| Genetic Predisposition to Disease | 67 | 2025 | 2266 | 3.690 |
Why?
| Peanut Hypersensitivity | 6 | 2023 | 140 | 3.090 |
Why?
| Asthma | 49 | 2025 | 2215 | 2.970 |
Why?
| Whole Genome Sequencing | 26 | 2025 | 131 | 2.460 |
Why?
| Dermatitis, Atopic | 9 | 2023 | 321 | 2.330 |
Why?
| Precision Medicine | 20 | 2025 | 383 | 2.250 |
Why?
| Genetic Variation | 30 | 2025 | 934 | 2.100 |
Why?
| Food Hypersensitivity | 4 | 2023 | 172 | 2.070 |
Why?
| Fatty Acid Desaturases | 12 | 2021 | 32 | 2.040 |
Why?
| Immunoglobulin E | 18 | 2021 | 329 | 1.890 |
Why?
| Genome, Human | 19 | 2025 | 392 | 1.880 |
Why?
| Arachis | 5 | 2023 | 108 | 1.860 |
Why?
| Platelet Aggregation | 12 | 2021 | 91 | 1.820 |
Why?
| Induced Pluripotent Stem Cells | 4 | 2021 | 223 | 1.730 |
Why?
| Genotype | 42 | 2025 | 1831 | 1.710 |
Why?
| Exome | 14 | 2022 | 220 | 1.680 |
Why?
| Blood Platelets | 12 | 2022 | 369 | 1.560 |
Why?
| Alleles | 22 | 2023 | 845 | 1.460 |
Why?
| Kaposi Varicelliform Eruption | 4 | 2021 | 22 | 1.450 |
Why?
| Genomics | 16 | 2025 | 716 | 1.430 |
Why?
| Megakaryocytes | 3 | 2021 | 31 | 1.320 |
Why?
| Phenotype | 50 | 2025 | 3050 | 1.250 |
Why?
| Quantitative Trait Loci | 18 | 2025 | 356 | 1.220 |
Why?
| Genetic Loci | 18 | 2021 | 274 | 1.220 |
Why?
| Fatty Acids, Omega-6 | 5 | 2017 | 47 | 1.200 |
Why?
| Humans | 232 | 2025 | 128524 | 1.170 |
Why?
| Multigene Family | 9 | 2021 | 198 | 1.080 |
Why?
| Coronary Artery Disease | 11 | 2025 | 677 | 1.070 |
Why?
| Receptors, Cell Surface | 8 | 2024 | 371 | 1.040 |
Why?
| DNA Methylation | 6 | 2024 | 604 | 1.000 |
Why?
| Gene Frequency | 23 | 2024 | 504 | 0.990 |
Why?
| Genetics, Population | 14 | 2021 | 200 | 0.960 |
Why?
| Linoleic Acid | 6 | 2023 | 40 | 0.930 |
Why?
| National Heart, Lung, and Blood Institute (U.S.) | 12 | 2022 | 101 | 0.910 |
Why?
| Nasal Mucosa | 2 | 2024 | 106 | 0.900 |
Why?
| Tacrolimus Binding Proteins | 1 | 2024 | 25 | 0.900 |
Why?
| Allergens | 5 | 2023 | 383 | 0.880 |
Why?
| Hypersensitivity, Immediate | 2 | 2023 | 44 | 0.870 |
Why?
| Transcriptome | 3 | 2022 | 881 | 0.850 |
Why?
| Genetic Linkage | 14 | 2022 | 299 | 0.830 |
Why?
| Models, Genetic | 14 | 2025 | 590 | 0.830 |
Why?
| HLA-DQ alpha-Chains | 2 | 2022 | 15 | 0.810 |
Why?
| Chromosome Mapping | 16 | 2021 | 505 | 0.780 |
Why?
| 2S Albumins, Plant | 1 | 2022 | 29 | 0.760 |
Why?
| Pulmonary Disease, Chronic Obstructive | 11 | 2021 | 950 | 0.760 |
Why?
| Linkage Disequilibrium | 19 | 2022 | 256 | 0.750 |
Why?
| Antigens, Plant | 1 | 2022 | 46 | 0.750 |
Why?
| Mosaicism | 4 | 2025 | 71 | 0.750 |
Why?
| Nucleotide Transport Proteins | 1 | 2021 | 1 | 0.740 |
Why?
| High-Throughput Nucleotide Sequencing | 6 | 2019 | 485 | 0.730 |
Why?
| Male | 106 | 2025 | 62883 | 0.730 |
Why?
| Immunoglobulin G | 2 | 2022 | 837 | 0.710 |
Why?
| Lipids | 8 | 2023 | 624 | 0.700 |
Why?
| Female | 107 | 2025 | 68127 | 0.690 |
Why?
| Antibody Formation | 1 | 2022 | 287 | 0.690 |
Why?
| Platelet Function Tests | 3 | 2021 | 25 | 0.680 |
Why?
| Herpesvirus 1, Human | 1 | 2021 | 85 | 0.670 |
Why?
| Middle Aged | 66 | 2025 | 30893 | 0.670 |
Why?
| Genetic Association Studies | 13 | 2024 | 359 | 0.660 |
Why?
| Multifactorial Inheritance | 4 | 2025 | 149 | 0.660 |
Why?
| Open Reading Frames | 3 | 2021 | 116 | 0.620 |
Why?
| Lung | 9 | 2022 | 3741 | 0.610 |
Why?
| Fibrinogen | 7 | 2024 | 158 | 0.600 |
Why?
| Adult | 63 | 2024 | 35315 | 0.580 |
Why?
| Alzheimer Disease | 1 | 2023 | 515 | 0.570 |
Why?
| Computational Biology | 5 | 2025 | 597 | 0.550 |
Why?
| Chromosomes, Human, Pair 11 | 5 | 2014 | 56 | 0.530 |
Why?
| Human Migration | 1 | 2016 | 21 | 0.530 |
Why?
| Pulmonary Emphysema | 3 | 2014 | 244 | 0.530 |
Why?
| Gene-Environment Interaction | 3 | 2014 | 185 | 0.530 |
Why?
| Platelet Activation | 4 | 2018 | 82 | 0.510 |
Why?
| Gene Flow | 1 | 2016 | 76 | 0.510 |
Why?
| Case-Control Studies | 20 | 2025 | 3326 | 0.490 |
Why?
| Software | 5 | 2024 | 610 | 0.490 |
Why?
| Diabetes Mellitus, Type 2 | 10 | 2022 | 2430 | 0.490 |
Why?
| Evolution, Molecular | 3 | 2019 | 467 | 0.480 |
Why?
| von Willebrand Factor | 5 | 2024 | 62 | 0.470 |
Why?
| Geography | 2 | 2016 | 186 | 0.460 |
Why?
| RNA | 1 | 2021 | 881 | 0.460 |
Why?
| HLA-B7 Antigen | 1 | 2013 | 6 | 0.440 |
Why?
| Diet | 4 | 2023 | 1200 | 0.430 |
Why?
| Fatty Acids, Unsaturated | 4 | 2020 | 95 | 0.430 |
Why?
| Polymorphism, Genetic | 11 | 2017 | 639 | 0.430 |
Why?
| Epigenesis, Genetic | 6 | 2024 | 616 | 0.420 |
Why?
| Bronchial Hyperreactivity | 1 | 2014 | 104 | 0.420 |
Why?
| Risk Factors | 22 | 2025 | 9727 | 0.420 |
Why?
| Haplotypes | 13 | 2025 | 471 | 0.420 |
Why?
| Pedigree | 7 | 2020 | 485 | 0.410 |
Why?
| Quantitative Trait, Heritable | 6 | 2021 | 119 | 0.410 |
Why?
| Interferon-gamma | 3 | 2015 | 761 | 0.410 |
Why?
| Hypersensitivity | 4 | 2024 | 249 | 0.390 |
Why?
| Child | 30 | 2025 | 20721 | 0.390 |
Why?
| Airway Obstruction | 1 | 2014 | 149 | 0.390 |
Why?
| Fatty Acids, Omega-3 | 3 | 2021 | 137 | 0.380 |
Why?
| Immunity, Cellular | 1 | 2013 | 267 | 0.370 |
Why?
| Mutation | 9 | 2024 | 3692 | 0.370 |
Why?
| Leukocytes | 4 | 2023 | 303 | 0.360 |
Why?
| Likelihood Functions | 5 | 2012 | 136 | 0.360 |
Why?
| Frailty | 2 | 2024 | 149 | 0.360 |
Why?
| Stearoyl-CoA Desaturase | 1 | 2011 | 62 | 0.360 |
Why?
| United States | 29 | 2024 | 13876 | 0.360 |
Why?
| Mendelian Randomization Analysis | 3 | 2024 | 50 | 0.360 |
Why?
| Dyslipidemias | 3 | 2016 | 177 | 0.350 |
Why?
| Factor VIII | 2 | 2024 | 56 | 0.340 |
Why?
| Aging | 4 | 2023 | 1770 | 0.340 |
Why?
| Diabetes Mellitus | 4 | 2023 | 1001 | 0.340 |
Why?
| Telomere | 5 | 2024 | 226 | 0.340 |
Why?
| Cohort Studies | 15 | 2021 | 5369 | 0.340 |
Why?
| Genome | 4 | 2022 | 277 | 0.340 |
Why?
| DNA, Mitochondrial | 2 | 2023 | 192 | 0.340 |
Why?
| Gene Expression Regulation | 9 | 2024 | 2506 | 0.330 |
Why?
| Cell Adhesion Molecules | 2 | 2024 | 172 | 0.330 |
Why?
| RNA, Long Noncoding | 2 | 2023 | 178 | 0.330 |
Why?
| Adolescent | 27 | 2023 | 20213 | 0.330 |
Why?
| Aged | 32 | 2025 | 21971 | 0.330 |
Why?
| Healthcare Disparities | 3 | 2025 | 576 | 0.330 |
Why?
| Biomarkers | 7 | 2024 | 3881 | 0.320 |
Why?
| Computer Simulation | 8 | 2024 | 939 | 0.310 |
Why?
| Organ Specificity | 2 | 2021 | 291 | 0.310 |
Why?
| Chromosome Aberrations | 2 | 2024 | 147 | 0.310 |
Why?
| Smoking | 6 | 2018 | 1463 | 0.310 |
Why?
| Adaptation, Physiological | 1 | 2012 | 514 | 0.310 |
Why?
| Genetic Pleiotropy | 3 | 2019 | 29 | 0.300 |
Why?
| Pharmacogenetics | 2 | 2020 | 171 | 0.300 |
Why?
| Dietary Fats | 1 | 2010 | 301 | 0.300 |
Why?
| Gene Regulatory Networks | 2 | 2024 | 281 | 0.290 |
Why?
| HLA-DQ beta-Chains | 2 | 2021 | 61 | 0.290 |
Why?
| Arachidonic Acid | 6 | 2015 | 114 | 0.290 |
Why?
| CD8-Positive T-Lymphocytes | 1 | 2013 | 840 | 0.280 |
Why?
| Fasting | 2 | 2022 | 263 | 0.280 |
Why?
| Body Height | 4 | 2015 | 192 | 0.270 |
Why?
| Loss of Function Mutation | 3 | 2021 | 39 | 0.270 |
Why?
| Restless Legs Syndrome | 1 | 2006 | 21 | 0.270 |
Why?
| Aspirin | 4 | 2018 | 378 | 0.260 |
Why?
| Carboxylic Ester Hydrolases | 1 | 2006 | 19 | 0.260 |
Why?
| Computer Graphics | 1 | 2006 | 41 | 0.260 |
Why?
| Cardiovascular Diseases | 7 | 2020 | 2018 | 0.260 |
Why?
| Polymorphism, Restriction Fragment Length | 1 | 2006 | 69 | 0.260 |
Why?
| Health Status Disparities | 3 | 2025 | 248 | 0.250 |
Why?
| Schistosoma japonicum | 2 | 2017 | 30 | 0.250 |
Why?
| Biological Specimen Banks | 3 | 2024 | 96 | 0.250 |
Why?
| Lipoprotein Lipase | 1 | 2006 | 58 | 0.250 |
Why?
| Oligonucleotide Array Sequence Analysis | 3 | 2017 | 756 | 0.250 |
Why?
| Hematopoietic Stem Cells | 3 | 2024 | 377 | 0.250 |
Why?
| Blood Proteins | 2 | 2024 | 236 | 0.240 |
Why?
| Serine | 1 | 2006 | 136 | 0.240 |
Why?
| Helminthiasis | 2 | 2017 | 11 | 0.240 |
Why?
| Endophenotypes | 1 | 2025 | 18 | 0.240 |
Why?
| Models, Statistical | 7 | 2021 | 625 | 0.240 |
Why?
| Liver | 6 | 2024 | 1827 | 0.240 |
Why?
| Hematopoiesis | 2 | 2023 | 185 | 0.240 |
Why?
| Genomic Structural Variation | 1 | 2025 | 12 | 0.240 |
Why?
| Membrane Proteins | 7 | 2017 | 1108 | 0.240 |
Why?
| Germ-Line Mutation | 2 | 2023 | 138 | 0.240 |
Why?
| Chromosomes, Human, Y | 1 | 2025 | 20 | 0.240 |
Why?
| Inflammation | 6 | 2024 | 2664 | 0.240 |
Why?
| Cholesterol, HDL | 4 | 2016 | 203 | 0.230 |
Why?
| Young Adult | 13 | 2022 | 12320 | 0.230 |
Why?
| Chromosome Deletion | 1 | 2025 | 102 | 0.230 |
Why?
| Consanguinity | 2 | 2005 | 47 | 0.230 |
Why?
| Tomography, X-Ray Computed | 2 | 2014 | 2521 | 0.230 |
Why?
| Kininogens | 1 | 2024 | 6 | 0.230 |
Why?
| Chromosomes, Human, Pair 16 | 3 | 2021 | 30 | 0.230 |
Why?
| Telomere Homeostasis | 1 | 2024 | 28 | 0.230 |
Why?
| Lectins, C-Type | 1 | 2024 | 64 | 0.220 |
Why?
| Interleukin-13 | 3 | 2023 | 145 | 0.220 |
Why?
| Chemokines, CC | 2 | 2014 | 32 | 0.220 |
Why?
| Liver Cirrhosis | 2 | 2017 | 273 | 0.220 |
Why?
| Forced Expiratory Volume | 4 | 2019 | 509 | 0.220 |
Why?
| Blood Pressure | 6 | 2022 | 1733 | 0.220 |
Why?
| Fibronectins | 1 | 2024 | 119 | 0.220 |
Why?
| Population Groups | 3 | 2019 | 57 | 0.220 |
Why?
| Menopause, Premature | 1 | 2023 | 9 | 0.220 |
Why?
| Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Protein | 2 | 2022 | 2 | 0.210 |
Why?
| Erythrocytes | 2 | 2021 | 670 | 0.210 |
Why?
| Barbados | 8 | 2013 | 8 | 0.210 |
Why?
| Proteomics | 3 | 2024 | 1004 | 0.210 |
Why?
| Respiration | 2 | 2014 | 190 | 0.210 |
Why?
| Metabolic Syndrome | 3 | 2011 | 340 | 0.210 |
Why?
| Blood Cells | 1 | 2022 | 38 | 0.210 |
Why?
| Frameshift Mutation | 1 | 2022 | 31 | 0.210 |
Why?
| Interleukin-4 | 2 | 2023 | 213 | 0.200 |
Why?
| Chromosomes, Human, X | 2 | 2021 | 72 | 0.200 |
Why?
| Promoter Regions, Genetic | 6 | 2023 | 1199 | 0.200 |
Why?
| Proteome | 2 | 2024 | 431 | 0.200 |
Why?
| Telomere Shortening | 1 | 2022 | 19 | 0.200 |
Why?
| Eczema | 1 | 2023 | 67 | 0.200 |
Why?
| Desensitization, Immunologic | 1 | 2023 | 89 | 0.190 |
Why?
| Acute Coronary Syndrome | 2 | 2016 | 267 | 0.190 |
Why?
| Genetic Heterogeneity | 3 | 2016 | 57 | 0.190 |
Why?
| Gastritis | 1 | 2023 | 97 | 0.190 |
Why?
| Nerve Tissue Proteins | 5 | 2022 | 567 | 0.190 |
Why?
| Pseudomonas Infections | 2 | 2015 | 211 | 0.190 |
Why?
| Coronary Disease | 2 | 2019 | 384 | 0.190 |
Why?
| Enteritis | 1 | 2023 | 94 | 0.190 |
Why?
| HLA-A2 Antigen | 1 | 2021 | 47 | 0.190 |
Why?
| Social Determinants of Health | 1 | 2025 | 217 | 0.190 |
Why?
| Dinoprostone | 1 | 2022 | 187 | 0.190 |
Why?
| Americas | 1 | 2021 | 19 | 0.180 |
Why?
| Spain | 1 | 2021 | 36 | 0.180 |
Why?
| Cyclooxygenase Inhibitors | 2 | 2014 | 80 | 0.180 |
Why?
| Peru | 1 | 2021 | 53 | 0.180 |
Why?
| DNA Copy Number Variations | 2 | 2020 | 169 | 0.180 |
Why?
| Gene Ontology | 1 | 2021 | 48 | 0.180 |
Why?
| Pulmonary Medicine | 2 | 2019 | 80 | 0.180 |
Why?
| Plasminogen Activator Inhibitor 1 | 1 | 2021 | 83 | 0.180 |
Why?
| Odds Ratio | 7 | 2019 | 1022 | 0.180 |
Why?
| Glutathione Transferase | 1 | 2021 | 99 | 0.180 |
Why?
| Cytokines | 4 | 2023 | 1985 | 0.180 |
Why?
| Lipid Metabolism | 2 | 2021 | 493 | 0.180 |
Why?
| Risk | 7 | 2019 | 852 | 0.180 |
Why?
| Immunologic Factors | 1 | 2022 | 229 | 0.170 |
Why?
| gamma-Linolenic Acid | 1 | 2020 | 2 | 0.170 |
Why?
| Chromosomes, Human, Pair 19 | 3 | 2012 | 23 | 0.170 |
Why?
| Energy Intake | 1 | 2023 | 453 | 0.170 |
Why?
| Receptors, Nicotinic | 2 | 2013 | 322 | 0.170 |
Why?
| Plant Oils | 1 | 2020 | 29 | 0.170 |
Why?
| Soybean Oil | 1 | 2020 | 14 | 0.170 |
Why?
| HLA-DQ Antigens | 1 | 2021 | 179 | 0.170 |
Why?
| Amish | 1 | 2020 | 7 | 0.170 |
Why?
| Thrombosis | 5 | 2024 | 321 | 0.170 |
Why?
| Platelet Aggregation Inhibitors | 2 | 2018 | 439 | 0.170 |
Why?
| beta-Globins | 1 | 2019 | 8 | 0.170 |
Why?
| Base Sequence | 4 | 2021 | 2134 | 0.170 |
Why?
| Genomic Instability | 1 | 2020 | 47 | 0.170 |
Why?
| Occipital Lobe | 1 | 2019 | 24 | 0.160 |
Why?
| Cholesterol, LDL | 5 | 2022 | 361 | 0.160 |
Why?
| Homozygote | 3 | 2016 | 191 | 0.160 |
Why?
| Diabetic Nephropathies | 1 | 2023 | 277 | 0.160 |
Why?
| Metabolomics | 2 | 2024 | 597 | 0.160 |
Why?
| Tissue Plasminogen Activator | 1 | 2021 | 220 | 0.160 |
Why?
| HLA-DRB1 Chains | 1 | 2020 | 108 | 0.160 |
Why?
| 8,11,14-Eicosatrienoic Acid | 3 | 2020 | 6 | 0.160 |
Why?
| Mutation, Missense | 2 | 2023 | 317 | 0.160 |
Why?
| Eicosanoids | 2 | 2022 | 55 | 0.160 |
Why?
| Parietal Lobe | 1 | 2019 | 48 | 0.160 |
Why?
| Brazil | 6 | 2017 | 104 | 0.160 |
Why?
| Chromosomes, Human, Pair 12 | 4 | 2019 | 21 | 0.160 |
Why?
| Photometry | 1 | 2019 | 4 | 0.160 |
Why?
| Clinical Trials as Topic | 2 | 2022 | 998 | 0.160 |
Why?
| Genes, Mitochondrial | 1 | 2018 | 12 | 0.160 |
Why?
| Flame Retardants | 1 | 2019 | 8 | 0.160 |
Why?
| Th2 Cells | 4 | 2023 | 167 | 0.160 |
Why?
| Chromatography, Gas | 1 | 2019 | 31 | 0.160 |
Why?
| Plasticizers | 1 | 2019 | 14 | 0.160 |
Why?
| Sleep Medicine Specialty | 1 | 2019 | 9 | 0.160 |
Why?
| Chromosomes, Human, Pair 6 | 2 | 2025 | 52 | 0.160 |
Why?
| Brain | 2 | 2023 | 2618 | 0.160 |
Why?
| India | 3 | 2009 | 170 | 0.160 |
Why?
| Temporal Lobe | 1 | 2019 | 85 | 0.160 |
Why?
| Sex Characteristics | 3 | 2014 | 727 | 0.160 |
Why?
| Receptors, Immunologic | 3 | 2022 | 209 | 0.160 |
Why?
| Metabolism | 1 | 2018 | 39 | 0.160 |
Why?
| Chromosomes, Human, Pair 18 | 1 | 2018 | 9 | 0.150 |
Why?
| Family | 4 | 2012 | 642 | 0.150 |
Why?
| Databases, Genetic | 4 | 2021 | 228 | 0.150 |
Why?
| Smad2 Protein | 1 | 2018 | 34 | 0.150 |
Why?
| Child, Preschool | 16 | 2021 | 10373 | 0.150 |
Why?
| Eosinophilic Esophagitis | 1 | 2023 | 318 | 0.150 |
Why?
| Blood Glucose | 4 | 2021 | 2092 | 0.150 |
Why?
| Hominidae | 1 | 2019 | 82 | 0.150 |
Why?
| Computer Communication Networks | 1 | 2018 | 32 | 0.150 |
Why?
| Frontal Lobe | 1 | 2019 | 151 | 0.150 |
Why?
| Exons | 3 | 2016 | 337 | 0.150 |
Why?
| Indians, North American | 2 | 2021 | 600 | 0.150 |
Why?
| Immunotherapy | 1 | 2022 | 585 | 0.150 |
Why?
| Telomerase | 2 | 2024 | 231 | 0.150 |
Why?
| Organophosphates | 1 | 2019 | 120 | 0.150 |
Why?
| DNA-Binding Proteins | 3 | 2020 | 1415 | 0.150 |
Why?
| Lipopolysaccharide Receptors | 2 | 2010 | 88 | 0.150 |
Why?
| Comorbidity | 1 | 2023 | 1540 | 0.150 |
Why?
| Pulmonary Surfactant-Associated Protein D | 1 | 2017 | 31 | 0.150 |
Why?
| Africa | 2 | 2020 | 98 | 0.140 |
Why?
| Molecular Targeted Therapy | 1 | 2020 | 387 | 0.140 |
Why?
| Noncommunicable Diseases | 1 | 2017 | 15 | 0.140 |
Why?
| Quality Control | 4 | 2021 | 156 | 0.140 |
Why?
| Information Storage and Retrieval | 1 | 2018 | 106 | 0.140 |
Why?
| Hyaluronoglucosaminidase | 1 | 2017 | 8 | 0.140 |
Why?
| Algorithms | 6 | 2025 | 1616 | 0.140 |
Why?
| Regulatory Sequences, Nucleic Acid | 1 | 2017 | 87 | 0.140 |
Why?
| Aged, 80 and over | 9 | 2020 | 7040 | 0.140 |
Why?
| Molecular Epidemiology | 3 | 2013 | 63 | 0.140 |
Why?
| Schistosoma mansoni | 1 | 2017 | 30 | 0.140 |
Why?
| Glomerular Filtration Rate | 1 | 2021 | 681 | 0.140 |
Why?
| Academic Medical Centers | 1 | 2020 | 473 | 0.140 |
Why?
| Endemic Diseases | 1 | 2017 | 30 | 0.140 |
Why?
| Interleukin-1 Receptor-Like 1 Protein | 1 | 2017 | 26 | 0.140 |
Why?
| Renal Insufficiency, Chronic | 1 | 2023 | 564 | 0.140 |
Why?
| Sequence Analysis, DNA | 6 | 2018 | 773 | 0.130 |
Why?
| Scavenger Receptors, Class B | 1 | 2016 | 11 | 0.130 |
Why?
| Decision Support Systems, Clinical | 1 | 2020 | 206 | 0.130 |
Why?
| DNA, Intergenic | 1 | 2016 | 24 | 0.130 |
Why?
| Cyclooxygenase 1 | 2 | 2014 | 26 | 0.130 |
Why?
| Schistosomiasis | 1 | 2017 | 38 | 0.130 |
Why?
| Enhancer Elements, Genetic | 1 | 2017 | 179 | 0.130 |
Why?
| White Matter | 1 | 2018 | 132 | 0.130 |
Why?
| Carotid Artery Diseases | 1 | 2016 | 65 | 0.130 |
Why?
| Immune System Diseases | 1 | 2016 | 33 | 0.130 |
Why?
| Animals | 18 | 2023 | 34501 | 0.130 |
Why?
| Erythropoiesis | 1 | 2016 | 50 | 0.130 |
Why?
| Adrenal Cortex Hormones | 1 | 2019 | 518 | 0.130 |
Why?
| Myocardial Infarction | 2 | 2020 | 1014 | 0.130 |
Why?
| Mitochondrial Proteins | 1 | 2018 | 238 | 0.130 |
Why?
| Transforming Growth Factor beta1 | 1 | 2017 | 155 | 0.130 |
Why?
| Kidney Transplantation | 2 | 2012 | 604 | 0.130 |
Why?
| Lung Diseases, Interstitial | 1 | 2022 | 592 | 0.130 |
Why?
| Sexism | 1 | 2016 | 55 | 0.130 |
Why?
| Cell Differentiation | 2 | 2021 | 1883 | 0.130 |
Why?
| Lipoprotein(a) | 1 | 2016 | 67 | 0.130 |
Why?
| United Kingdom | 3 | 2021 | 256 | 0.130 |
Why?
| Anthropometry | 2 | 2022 | 204 | 0.130 |
Why?
| Leukocytes, Mononuclear | 2 | 2021 | 538 | 0.120 |
Why?
| Genes, Modifier | 1 | 2015 | 2 | 0.120 |
Why?
| Caveolin 2 | 1 | 2015 | 2 | 0.120 |
Why?
| Respiratory Tract Diseases | 1 | 2017 | 150 | 0.120 |
Why?
| CpG Islands | 3 | 2023 | 152 | 0.120 |
Why?
| Factor VII | 1 | 2015 | 22 | 0.120 |
Why?
| Molecular Sequence Annotation | 3 | 2021 | 88 | 0.120 |
Why?
| Receptors, Interferon | 1 | 2015 | 50 | 0.120 |
Why?
| Collagen | 2 | 2015 | 429 | 0.120 |
Why?
| Schistosomiasis japonica | 1 | 2015 | 32 | 0.120 |
Why?
| Mutation Rate | 1 | 2015 | 25 | 0.120 |
Why?
| Scleroderma, Systemic | 1 | 2016 | 104 | 0.120 |
Why?
| Minority Groups | 1 | 2017 | 251 | 0.120 |
Why?
| Adenosine Triphosphatases | 1 | 2016 | 161 | 0.120 |
Why?
| Interleukin-10 | 2 | 2017 | 299 | 0.120 |
Why?
| Mutant Chimeric Proteins | 1 | 2014 | 3 | 0.120 |
Why?
| KCNQ1 Potassium Channel | 1 | 2014 | 7 | 0.120 |
Why?
| Menopause | 2 | 2023 | 303 | 0.120 |
Why?
| Severity of Illness Index | 4 | 2019 | 2736 | 0.120 |
Why?
| HMGA2 Protein | 1 | 2014 | 9 | 0.120 |
Why?
| HLA-B27 Antigen | 1 | 2014 | 15 | 0.120 |
Why?
| Chromosome Disorders | 1 | 2014 | 39 | 0.120 |
Why?
| Transcription Factor 7-Like 2 Protein | 1 | 2014 | 22 | 0.120 |
Why?
| Hypertension | 2 | 2022 | 1238 | 0.110 |
Why?
| Rhinitis, Allergic | 1 | 2014 | 38 | 0.110 |
Why?
| Cystic Fibrosis | 2 | 2015 | 1057 | 0.110 |
Why?
| Body Mass Index | 5 | 2022 | 2262 | 0.110 |
Why?
| Family Health | 4 | 2011 | 194 | 0.110 |
Why?
| Obesity | 2 | 2022 | 2860 | 0.110 |
Why?
| Critical Care | 1 | 2019 | 544 | 0.110 |
Why?
| Transmembrane Activator and CAML Interactor Protein | 1 | 2013 | 3 | 0.110 |
Why?
| beta-Defensins | 1 | 2013 | 21 | 0.110 |
Why?
| Stroke | 1 | 2022 | 1064 | 0.110 |
Why?
| Longitudinal Studies | 5 | 2021 | 2697 | 0.110 |
Why?
| Tobacco Use Disorder | 2 | 2013 | 239 | 0.110 |
Why?
| Pseudomonas aeruginosa | 2 | 2015 | 334 | 0.110 |
Why?
| Vital Capacity | 1 | 2014 | 289 | 0.110 |
Why?
| Dietary Supplements | 1 | 2017 | 529 | 0.110 |
Why?
| Kv Channel-Interacting Proteins | 1 | 2013 | 3 | 0.110 |
Why?
| Chemokine CXCL12 | 1 | 2013 | 77 | 0.110 |
Why?
| Cells, Cultured | 1 | 2021 | 4008 | 0.110 |
Why?
| Chromosomes, Human, Pair 1 | 2 | 2011 | 70 | 0.100 |
Why?
| Virginia | 2 | 2005 | 59 | 0.100 |
Why?
| HEK293 Cells | 3 | 2021 | 681 | 0.100 |
Why?
| Parents | 3 | 2007 | 1306 | 0.100 |
Why?
| Cross-Sectional Studies | 5 | 2024 | 5040 | 0.100 |
Why?
| Nuclear Proteins | 1 | 2017 | 648 | 0.100 |
Why?
| Genetic Markers | 5 | 2016 | 339 | 0.100 |
Why?
| K562 Cells | 2 | 2024 | 82 | 0.100 |
Why?
| Principal Component Analysis | 2 | 2010 | 184 | 0.100 |
Why?
| Skin Tests | 4 | 2017 | 100 | 0.100 |
Why?
| Hepatocyte Nuclear Factor 3-alpha | 1 | 2012 | 8 | 0.100 |
Why?
| Ankyrins | 1 | 2012 | 9 | 0.100 |
Why?
| Fatty Acids | 1 | 2015 | 413 | 0.100 |
Why?
| Duffy Blood-Group System | 2 | 2011 | 6 | 0.100 |
Why?
| Kallikreins | 1 | 2012 | 29 | 0.100 |
Why?
| Phylogeny | 1 | 2016 | 846 | 0.100 |
Why?
| Mitochondria | 1 | 2018 | 844 | 0.100 |
Why?
| Microbiota | 1 | 2020 | 720 | 0.100 |
Why?
| Atherosclerosis | 1 | 2016 | 405 | 0.100 |
Why?
| Triglycerides | 3 | 2015 | 524 | 0.100 |
Why?
| Leukocyte Count | 2 | 2011 | 327 | 0.100 |
Why?
| Respiratory Sounds | 1 | 2012 | 120 | 0.100 |
Why?
| Prostate-Specific Antigen | 1 | 2012 | 160 | 0.100 |
Why?
| Insulin | 4 | 2022 | 2318 | 0.090 |
Why?
| Steroids | 1 | 2012 | 148 | 0.090 |
Why?
| Infant | 9 | 2021 | 8913 | 0.090 |
Why?
| Heterozygote | 3 | 2021 | 266 | 0.090 |
Why?
| Reproducibility of Results | 6 | 2021 | 3023 | 0.090 |
Why?
| Cyclin-Dependent Kinase Inhibitor p15 | 1 | 2011 | 16 | 0.090 |
Why?
| Chromosomes, Human, Pair 9 | 1 | 2011 | 39 | 0.090 |
Why?
| Aquaporin 5 | 1 | 2010 | 2 | 0.090 |
Why?
| Disease Progression | 5 | 2019 | 2603 | 0.090 |
Why?
| Microtubule-Associated Proteins | 1 | 2012 | 189 | 0.090 |
Why?
| Chromosomes | 1 | 2011 | 101 | 0.090 |
Why?
| Heredity | 2 | 2021 | 12 | 0.090 |
Why?
| Cockroaches | 1 | 2010 | 20 | 0.090 |
Why?
| Mice | 10 | 2023 | 16579 | 0.090 |
Why?
| Chromosomes, Human, Pair 5 | 1 | 2010 | 29 | 0.090 |
Why?
| Interviews as Topic | 2 | 2006 | 705 | 0.090 |
Why?
| Recombination, Genetic | 1 | 2011 | 188 | 0.090 |
Why?
| Death Domain Receptor Signaling Adaptor Proteins | 1 | 2009 | 2 | 0.090 |
Why?
| Antigens, Differentiation, B-Lymphocyte | 1 | 2010 | 37 | 0.080 |
Why?
| Incidence | 4 | 2019 | 2619 | 0.080 |
Why?
| Health Services Accessibility | 1 | 2017 | 892 | 0.080 |
Why?
| Magnetic Resonance Imaging | 2 | 2019 | 3366 | 0.080 |
Why?
| Myocardial Ischemia | 1 | 2011 | 249 | 0.080 |
Why?
| Eosinophils | 2 | 2025 | 323 | 0.080 |
Why?
| Lectins | 1 | 2010 | 46 | 0.080 |
Why?
| Receptors, Kainic Acid | 1 | 2009 | 10 | 0.080 |
Why?
| Nuclear Family | 2 | 2007 | 51 | 0.080 |
Why?
| Guanine Nucleotide Exchange Factors | 1 | 2009 | 63 | 0.080 |
Why?
| Prostaglandin-Endoperoxide Synthases | 1 | 2009 | 73 | 0.080 |
Why?
| Cyclic Nucleotide Phosphodiesterases, Type 4 | 1 | 2009 | 9 | 0.080 |
Why?
| Isoenzymes | 1 | 2010 | 304 | 0.080 |
Why?
| Chromosomes, Human | 1 | 2009 | 41 | 0.080 |
Why?
| Machine Learning | 2 | 2025 | 432 | 0.080 |
Why?
| Tryptophan | 1 | 2010 | 169 | 0.080 |
Why?
| Caribbean Region | 4 | 2011 | 22 | 0.080 |
Why?
| Receptors, Leptin | 1 | 2009 | 23 | 0.080 |
Why?
| Confidence Intervals | 2 | 2014 | 318 | 0.080 |
Why?
| Interferon-alpha | 1 | 2010 | 192 | 0.080 |
Why?
| Arginine | 1 | 2010 | 258 | 0.080 |
Why?
| Nephrotic Syndrome | 1 | 1989 | 28 | 0.080 |
Why?
| Agammaglobulinemia | 1 | 1989 | 33 | 0.080 |
Why?
| Graft Rejection | 1 | 2012 | 557 | 0.080 |
Why?
| Receptors, Transforming Growth Factor beta | 1 | 2009 | 52 | 0.080 |
Why?
| Regression Analysis | 3 | 2025 | 983 | 0.080 |
Why?
| Intercellular Signaling Peptides and Proteins | 2 | 2022 | 371 | 0.080 |
Why?
| Genotyping Techniques | 2 | 2019 | 72 | 0.080 |
Why?
| Cholesterol | 2 | 2015 | 406 | 0.080 |
Why?
| Thromboxane B2 | 3 | 2018 | 26 | 0.080 |
Why?
| Proteoglycans | 1 | 2009 | 109 | 0.070 |
Why?
| Alcoholism | 3 | 2005 | 766 | 0.070 |
Why?
| Siblings | 2 | 2011 | 215 | 0.070 |
Why?
| Immunosuppressive Agents | 1 | 2012 | 686 | 0.070 |
Why?
| Polymerase Chain Reaction | 2 | 2012 | 1019 | 0.070 |
Why?
| Chromosomes, Human, Pair 17 | 3 | 2019 | 54 | 0.070 |
Why?
| Research Design | 2 | 2019 | 1038 | 0.070 |
Why?
| Cognition | 1 | 2015 | 1107 | 0.070 |
Why?
| Myosin-Light-Chain Kinase | 1 | 2007 | 20 | 0.070 |
Why?
| Antigens, CD | 1 | 2010 | 479 | 0.070 |
Why?
| Databases, Factual | 1 | 2012 | 1268 | 0.070 |
Why?
| Infant, Newborn | 6 | 2012 | 5687 | 0.070 |
Why?
| Age of Onset | 3 | 2013 | 493 | 0.070 |
Why?
| Registries | 1 | 2014 | 1878 | 0.070 |
Why?
| Thrombophilia | 1 | 2007 | 66 | 0.070 |
Why?
| Inheritance Patterns | 1 | 2006 | 46 | 0.070 |
Why?
| Deoxyribonuclease HindIII | 1 | 2006 | 3 | 0.070 |
Why?
| alpha-Linolenic Acid | 2 | 2017 | 8 | 0.060 |
Why?
| Europe | 2 | 2020 | 362 | 0.060 |
Why?
| Meta-Analysis as Topic | 3 | 2012 | 167 | 0.060 |
Why?
| Prospective Studies | 5 | 2020 | 7043 | 0.060 |
Why?
| Adenosine Diphosphate | 2 | 2017 | 78 | 0.060 |
Why?
| Neoplasm Proteins | 2 | 2022 | 421 | 0.060 |
Why?
| Platelet Count | 2 | 2016 | 82 | 0.060 |
Why?
| Chromosomes, Human, Pair 4 | 2 | 2019 | 28 | 0.060 |
Why?
| Epinephrine | 2 | 2017 | 137 | 0.060 |
Why?
| DNA Mutational Analysis | 2 | 2020 | 386 | 0.060 |
Why?
| Glucose | 2 | 2022 | 983 | 0.060 |
Why?
| Transfection | 3 | 2016 | 895 | 0.060 |
Why?
| Mucins | 1 | 2005 | 69 | 0.060 |
Why?
| Complement C3 | 1 | 2006 | 198 | 0.060 |
Why?
| Receptors, Prostaglandin | 1 | 2004 | 21 | 0.060 |
Why?
| Immunoglobulins | 1 | 2005 | 157 | 0.060 |
Why?
| Hypertension, Pulmonary | 1 | 2016 | 1735 | 0.060 |
Why?
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2024 | 25 | 0.060 |
Why?
| Mites | 1 | 2004 | 6 | 0.060 |
Why?
| Janus Kinase 2 | 1 | 2024 | 32 | 0.060 |
Why?
| Loss of Heterozygosity | 1 | 2024 | 46 | 0.060 |
Why?
| National Institute of Allergy and Infectious Diseases (U.S.) | 1 | 2024 | 21 | 0.060 |
Why?
| Eye Proteins | 2 | 2021 | 87 | 0.060 |
Why?
| Gene Targeting | 2 | 2020 | 82 | 0.060 |
Why?
| Chromosomes, Human, Pair 14 | 2 | 2014 | 18 | 0.060 |
Why?
| Matched-Pair Analysis | 1 | 2003 | 43 | 0.060 |
Why?
| Disease Models, Animal | 1 | 2014 | 3943 | 0.060 |
Why?
| Adult Children | 1 | 2003 | 23 | 0.060 |
Why?
| Societies, Medical | 2 | 2019 | 749 | 0.060 |
Why?
| Diabetic Retinopathy | 1 | 2006 | 171 | 0.050 |
Why?
| Time | 1 | 2003 | 75 | 0.050 |
Why?
| Receptors, Complement | 1 | 2004 | 120 | 0.050 |
Why?
| Epigenomics | 1 | 2024 | 111 | 0.050 |
Why?
| Guanine Nucleotide Dissociation Inhibitors | 1 | 2023 | 2 | 0.050 |
Why?
| Human Umbilical Vein Endothelial Cells | 1 | 2024 | 97 | 0.050 |
Why?
| Genes | 1 | 2003 | 226 | 0.050 |
Why?
| Sex Factors | 3 | 2014 | 1949 | 0.050 |
Why?
| Electroencephalography | 1 | 2005 | 393 | 0.050 |
Why?
| Gene Expression Profiling | 1 | 2010 | 1687 | 0.050 |
Why?
| Point Mutation | 1 | 2004 | 224 | 0.050 |
Why?
| Aminopeptidases | 1 | 2023 | 14 | 0.050 |
Why?
| RNA, Messenger | 2 | 2016 | 2674 | 0.050 |
Why?
| Membrane Glycoproteins | 2 | 2005 | 466 | 0.050 |
Why?
| CRISPR-Cas Systems | 1 | 2024 | 110 | 0.050 |
Why?
| Environment | 2 | 2010 | 347 | 0.050 |
Why?
| Cooperative Behavior | 1 | 2005 | 425 | 0.050 |
Why?
| Cell Line | 3 | 2015 | 2731 | 0.050 |
Why?
| Genes, Reporter | 2 | 2015 | 266 | 0.050 |
Why?
| Pore Forming Cytotoxic Proteins | 1 | 2022 | 16 | 0.050 |
Why?
| Pruritus | 1 | 2023 | 59 | 0.050 |
Why?
| Syndrome | 1 | 2023 | 335 | 0.050 |
Why?
| Frail Elderly | 1 | 2023 | 119 | 0.050 |
Why?
| Fruit | 1 | 2023 | 131 | 0.050 |
Why?
| Vegetables | 1 | 2023 | 147 | 0.050 |
Why?
| Colorado | 2 | 2024 | 4392 | 0.050 |
Why?
| Age Factors | 3 | 2003 | 3117 | 0.050 |
Why?
| Gene Expression | 3 | 2015 | 1462 | 0.050 |
Why?
| Nutrition Surveys | 1 | 2023 | 262 | 0.050 |
Why?
| RGS Proteins | 1 | 2021 | 14 | 0.050 |
Why?
| Internationality | 2 | 2013 | 148 | 0.050 |
Why?
| Subcutaneous Tissue | 1 | 2021 | 22 | 0.050 |
Why?
| INDEL Mutation | 1 | 2021 | 15 | 0.050 |
Why?
| Colombia | 2 | 2013 | 36 | 0.050 |
Why?
| Postmenopause | 1 | 2023 | 370 | 0.050 |
Why?
| Cytochrome P-450 CYP2D6 | 1 | 2021 | 29 | 0.050 |
Why?
| Sepsis | 1 | 2007 | 556 | 0.040 |
Why?
| alpha Karyopherins | 1 | 2020 | 11 | 0.040 |
Why?
| Receptors, LDL | 1 | 2020 | 45 | 0.040 |
Why?
| Prognosis | 2 | 2021 | 3780 | 0.040 |
Why?
| Antibodies, Heterophile | 1 | 2000 | 13 | 0.040 |
Why?
| Datasets as Topic | 1 | 2021 | 110 | 0.040 |
Why?
| Lymphocytosis | 1 | 2000 | 10 | 0.040 |
Why?
| Tripartite Motif Proteins | 1 | 2020 | 31 | 0.040 |
Why?
| Fibrin Fibrinogen Degradation Products | 1 | 2021 | 82 | 0.040 |
Why?
| GTP-Binding Proteins | 1 | 2021 | 155 | 0.040 |
Why?
| Sample Size | 1 | 2021 | 115 | 0.040 |
Why?
| Public Health Surveillance | 1 | 2021 | 67 | 0.040 |
Why?
| Population Density | 1 | 2021 | 91 | 0.040 |
Why?
| Lod Score | 3 | 2009 | 66 | 0.040 |
Why?
| Dioxygenases | 1 | 2020 | 29 | 0.040 |
Why?
| Gene Editing | 1 | 2021 | 68 | 0.040 |
Why?
| Lens, Crystalline | 1 | 2001 | 100 | 0.040 |
Why?
| Cell Self Renewal | 1 | 2020 | 54 | 0.040 |
Why?
| Eating | 1 | 2023 | 365 | 0.040 |
Why?
| Interleukin-6 | 1 | 2024 | 716 | 0.040 |
Why?
| Names | 1 | 2000 | 12 | 0.040 |
Why?
| Immunity, Innate | 1 | 2006 | 803 | 0.040 |
Why?
| Mutagenesis | 1 | 2021 | 181 | 0.040 |
Why?
| Respiratory Function Tests | 2 | 2013 | 582 | 0.040 |
Why?
| Mucin-5B | 1 | 2022 | 218 | 0.040 |
Why?
| Cytochrome P-450 CYP2C19 | 1 | 2020 | 23 | 0.040 |
Why?
| Fibrinolysis | 1 | 2021 | 133 | 0.040 |
Why?
| Gene Silencing | 1 | 2020 | 185 | 0.040 |
Why?
| A549 Cells | 1 | 2019 | 58 | 0.040 |
Why?
| Emigration and Immigration | 1 | 2000 | 50 | 0.040 |
Why?
| North America | 2 | 2011 | 289 | 0.040 |
Why?
| Siberia | 1 | 2019 | 9 | 0.040 |
Why?
| Body Weight | 1 | 2003 | 931 | 0.040 |
Why?
| Information Dissemination | 1 | 2021 | 204 | 0.040 |
Why?
| Recombinases | 1 | 2019 | 6 | 0.040 |
Why?
| Flame Ionization | 1 | 2019 | 2 | 0.040 |
Why?
| Event-Related Potentials, P300 | 1 | 1999 | 14 | 0.040 |
Why?
| Cloud Computing | 1 | 2019 | 7 | 0.040 |
Why?
| Cataract | 1 | 2001 | 194 | 0.040 |
Why?
| Waist-Hip Ratio | 1 | 2018 | 36 | 0.040 |
Why?
| Proportional Hazards Models | 2 | 2014 | 1208 | 0.040 |
Why?
| Chromosomes, Human, Pair 8 | 1 | 2019 | 36 | 0.040 |
Why?
| Linear Models | 2 | 2017 | 816 | 0.040 |
Why?
| Monoamine Oxidase | 1 | 1999 | 27 | 0.040 |
Why?
| Limit of Detection | 1 | 2019 | 55 | 0.040 |
Why?
| Prevalence | 2 | 2016 | 2549 | 0.040 |
Why?
| Cell Cycle Proteins | 1 | 2022 | 580 | 0.040 |
Why?
| Endothelial Cells | 1 | 2024 | 701 | 0.040 |
Why?
| RNA Splicing Factors | 1 | 2019 | 51 | 0.040 |
Why?
| Calibration | 1 | 2019 | 135 | 0.040 |
Why?
| Organ Size | 1 | 2019 | 440 | 0.040 |
Why?
| Reference Standards | 1 | 2019 | 170 | 0.040 |
Why?
| Large-Conductance Calcium-Activated Potassium Channel alpha Subunits | 1 | 2018 | 9 | 0.040 |
Why?
| Disease Susceptibility | 2 | 2014 | 334 | 0.040 |
Why?
| Virus Diseases | 1 | 2000 | 204 | 0.040 |
Why?
| Administration, Inhalation | 1 | 2019 | 664 | 0.040 |
Why?
| Skin | 1 | 2023 | 717 | 0.040 |
Why?
| Rhinitis, Allergic, Seasonal | 1 | 2017 | 31 | 0.040 |
Why?
| Histone Code | 1 | 2017 | 31 | 0.040 |
Why?
| Intracellular Signaling Peptides and Proteins | 1 | 2020 | 425 | 0.040 |
Why?
| Neoplasms | 1 | 2012 | 2465 | 0.040 |
Why?
| Selection, Genetic | 1 | 2019 | 250 | 0.030 |
Why?
| Adipocytes | 1 | 2018 | 204 | 0.030 |
Why?
| Workflow | 1 | 2018 | 149 | 0.030 |
Why?
| Program Evaluation | 1 | 2021 | 874 | 0.030 |
Why?
| Apolipoprotein B-100 | 1 | 2016 | 10 | 0.030 |
Why?
| Apolipoprotein E2 | 1 | 2016 | 3 | 0.030 |
Why?
| Time Factors | 2 | 2019 | 6503 | 0.030 |
Why?
| Proto-Oncogene Proteins | 1 | 2020 | 634 | 0.030 |
Why?
| GPI-Linked Proteins | 1 | 2017 | 67 | 0.030 |
Why?
| Pilot Projects | 1 | 2022 | 1558 | 0.030 |
Why?
| Alternative Splicing | 1 | 2019 | 218 | 0.030 |
Why?
| Interleukin-33 | 1 | 2017 | 49 | 0.030 |
Why?
| T-Lymphocytes | 1 | 2005 | 1922 | 0.030 |
Why?
| Demography | 1 | 2017 | 277 | 0.030 |
Why?
| Denmark | 1 | 2016 | 44 | 0.030 |
Why?
| Cluster Analysis | 1 | 2018 | 478 | 0.030 |
Why?
| Mean Platelet Volume | 1 | 2016 | 3 | 0.030 |
Why?
| Follow-Up Studies | 2 | 2019 | 4898 | 0.030 |
Why?
| Data Accuracy | 1 | 2017 | 59 | 0.030 |
Why?
| Allelic Imbalance | 1 | 2016 | 8 | 0.030 |
Why?
| Massachusetts | 1 | 2017 | 158 | 0.030 |
Why?
| Erythrocyte Indices | 1 | 2016 | 27 | 0.030 |
Why?
| Blood Cell Count | 1 | 2016 | 54 | 0.030 |
Why?
| Antibodies, Viral | 1 | 2000 | 593 | 0.030 |
Why?
| China | 1 | 2017 | 191 | 0.030 |
Why?
| Hematocrit | 1 | 2016 | 94 | 0.030 |
Why?
| Carotid Intima-Media Thickness | 1 | 2016 | 91 | 0.030 |
Why?
| Asymptomatic Diseases | 1 | 2016 | 85 | 0.030 |
Why?
| CD4-Positive T-Lymphocytes | 2 | 2014 | 1046 | 0.030 |
Why?
| DNA | 1 | 2023 | 1392 | 0.030 |
Why?
| Stearic Acids | 1 | 2015 | 14 | 0.030 |
Why?
| Sarcoglycans | 1 | 2015 | 4 | 0.030 |
Why?
| Computed Tomography Angiography | 1 | 2016 | 112 | 0.030 |
Why?
| Kidney | 1 | 2023 | 1305 | 0.030 |
Why?
| Amino Acid Substitution | 1 | 2016 | 281 | 0.030 |
Why?
| Lung Volume Measurements | 1 | 2015 | 43 | 0.030 |
Why?
| Bias | 1 | 2016 | 195 | 0.030 |
Why?
| Double-Blind Method | 1 | 2020 | 1860 | 0.030 |
Why?
| Protein Transport | 1 | 2017 | 422 | 0.030 |
Why?
| STAT1 Transcription Factor | 1 | 2015 | 70 | 0.030 |
Why?
| Multivariate Analysis | 1 | 2019 | 1494 | 0.030 |
Why?
| Glucose-6-Phosphatase | 1 | 2015 | 31 | 0.030 |
Why?
| Vascular Calcification | 1 | 2016 | 107 | 0.030 |
Why?
| Nutritional Status | 1 | 2017 | 326 | 0.030 |
Why?
| Social Class | 1 | 2017 | 259 | 0.030 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2016 | 326 | 0.030 |
Why?
| Phosphoproteins | 1 | 2017 | 330 | 0.030 |
Why?
| Coronary Angiography | 1 | 2016 | 306 | 0.030 |
Why?
| Leukotriene B4 | 1 | 2014 | 40 | 0.030 |
Why?
| Pneumothorax | 1 | 2014 | 40 | 0.030 |
Why?
| Potassium Channels | 1 | 2015 | 143 | 0.030 |
Why?
| Gene Expression Regulation, Developmental | 1 | 2019 | 815 | 0.030 |
Why?
| Host-Parasite Interactions | 1 | 2015 | 98 | 0.030 |
Why?
| Dose-Response Relationship, Drug | 1 | 2018 | 1943 | 0.030 |
Why?
| Myosin Heavy Chains | 1 | 2015 | 173 | 0.030 |
Why?
| Glucagon-Like Peptide-1 Receptor | 1 | 2015 | 91 | 0.030 |
Why?
| Fibrosis | 1 | 2017 | 522 | 0.030 |
Why?
| Hemoglobins | 1 | 2016 | 336 | 0.030 |
Why?
| Health Policy | 1 | 2017 | 353 | 0.030 |
Why?
| Smoking Cessation | 1 | 2018 | 408 | 0.030 |
Why?
| Stress, Psychological | 1 | 2022 | 1058 | 0.030 |
Why?
| Diet, Western | 1 | 2014 | 79 | 0.030 |
Why?
| alpha 1-Antitrypsin | 1 | 2014 | 103 | 0.030 |
Why?
| Rats, Sprague-Dawley | 1 | 2019 | 2245 | 0.030 |
Why?
| Jamaica | 1 | 2013 | 2 | 0.030 |
Why?
| Up-Regulation | 1 | 2016 | 826 | 0.030 |
Why?
| District of Columbia | 1 | 2013 | 26 | 0.030 |
Why?
| Metabolic Networks and Pathways | 1 | 2014 | 175 | 0.030 |
Why?
| Cotinine | 1 | 2013 | 75 | 0.030 |
Why?
| Gene Order | 1 | 2012 | 26 | 0.030 |
Why?
| New York | 1 | 2013 | 123 | 0.030 |
Why?
| Educational Status | 1 | 2015 | 470 | 0.030 |
Why?
| Chromosomes, Human, Pair 10 | 1 | 2012 | 18 | 0.030 |
Why?
| Dynactin Complex | 1 | 2012 | 4 | 0.030 |
Why?
| Surveys and Questionnaires | 2 | 2009 | 5346 | 0.030 |
Why?
| Immunity, Mucosal | 1 | 2013 | 87 | 0.030 |
Why?
| Untranslated Regions | 1 | 2012 | 3 | 0.020 |
Why?
| Kaplan-Meier Estimate | 1 | 2014 | 857 | 0.020 |
Why?
| Wales | 1 | 2011 | 17 | 0.020 |
Why?
| Statistics, Nonparametric | 2 | 2005 | 423 | 0.020 |
Why?
| Adolescent Development | 1 | 2012 | 82 | 0.020 |
Why?
| Chemokine CXCL2 | 1 | 2011 | 43 | 0.020 |
Why?
| England | 1 | 2011 | 70 | 0.020 |
Why?
| Biological Evolution | 1 | 2015 | 426 | 0.020 |
Why?
| Canada | 1 | 2012 | 345 | 0.020 |
Why?
| Epidemiologic Methods | 1 | 2011 | 74 | 0.020 |
Why?
| X Chromosome Inactivation | 1 | 2011 | 23 | 0.020 |
Why?
| Eicosapentaenoic Acid | 1 | 2011 | 36 | 0.020 |
Why?
| Luciferases | 1 | 2011 | 147 | 0.020 |
Why?
| Microsatellite Repeats | 2 | 2003 | 161 | 0.020 |
Why?
| Inflammation Mediators | 1 | 2014 | 500 | 0.020 |
Why?
| Overweight | 1 | 2015 | 525 | 0.020 |
Why?
| Costa Rica | 1 | 2010 | 16 | 0.020 |
Why?
| Pulmonary Fibrosis | 1 | 2014 | 374 | 0.020 |
Why?
| Artifacts | 1 | 2011 | 121 | 0.020 |
Why?
| Chronic Disease | 1 | 2017 | 1701 | 0.020 |
Why?
| Codon, Nonsense | 1 | 2010 | 39 | 0.020 |
Why?
| Carrier Proteins | 1 | 2015 | 731 | 0.020 |
Why?
| Salmeterol Xinafoate | 1 | 2010 | 41 | 0.020 |
Why?
| Age Distribution | 1 | 2011 | 376 | 0.020 |
Why?
| Microfilament Proteins | 1 | 2011 | 125 | 0.020 |
Why?
| Sex Distribution | 1 | 2011 | 359 | 0.020 |
Why?
| Introns | 1 | 2011 | 245 | 0.020 |
Why?
| Markov Chains | 1 | 2010 | 116 | 0.020 |
Why?
| Albuterol | 1 | 2010 | 104 | 0.020 |
Why?
| Urban Population | 1 | 2012 | 438 | 0.020 |
Why?
| Nicotine | 1 | 2012 | 303 | 0.020 |
Why?
| Plasmids | 1 | 2010 | 357 | 0.020 |
Why?
| Coculture Techniques | 1 | 2010 | 225 | 0.020 |
Why?
| Kainic Acid | 1 | 2009 | 34 | 0.020 |
Why?
| Waist Circumference | 1 | 2010 | 138 | 0.020 |
Why?
| Acute Disease | 1 | 2012 | 968 | 0.020 |
Why?
| Excitatory Amino Acid Agonists | 1 | 2009 | 39 | 0.020 |
Why?
| Analysis of Variance | 1 | 2012 | 1271 | 0.020 |
Why?
| DNA Replication | 1 | 2011 | 224 | 0.020 |
Why?
| Mice, Knockout | 2 | 2009 | 2752 | 0.020 |
Why?
| Receptors, Tumor Necrosis Factor | 1 | 2009 | 162 | 0.020 |
Why?
| Bronchodilator Agents | 1 | 2010 | 245 | 0.020 |
Why?
| Disease | 1 | 2009 | 94 | 0.020 |
Why?
| Spirometry | 1 | 2009 | 248 | 0.020 |
Why?
| Korea | 1 | 2007 | 9 | 0.020 |
Why?
| Quality of Life | 1 | 2019 | 2680 | 0.020 |
Why?
| Sensitivity and Specificity | 1 | 2012 | 1820 | 0.020 |
Why?
| beta-Thromboglobulin | 1 | 2007 | 3 | 0.020 |
Why?
| Risk Assessment | 1 | 2016 | 3256 | 0.020 |
Why?
| Binding Sites | 1 | 2010 | 1239 | 0.020 |
Why?
| Dendritic Cells | 1 | 2010 | 477 | 0.020 |
Why?
| Transcription Factors | 1 | 2014 | 1631 | 0.020 |
Why?
| Drug Resistance | 1 | 2007 | 163 | 0.020 |
Why?
| Receptor for Advanced Glycation End Products | 1 | 2006 | 30 | 0.020 |
Why?
| Models, Theoretical | 1 | 2009 | 546 | 0.020 |
Why?
| Genetic Testing | 2 | 1999 | 427 | 0.020 |
Why?
| False Positive Reactions | 1 | 2005 | 113 | 0.020 |
Why?
| Chromosomes, Human, Pair 21 | 1 | 2005 | 42 | 0.020 |
Why?
| Hepatitis A Antibodies | 1 | 2005 | 3 | 0.020 |
Why?
| Hepatitis A Virus Cellular Receptor 1 | 1 | 2005 | 43 | 0.020 |
Why?
| Hepatitis A Virus Cellular Receptor 2 | 1 | 2005 | 30 | 0.020 |
Why?
| Hepatitis A | 1 | 2005 | 25 | 0.020 |
Why?
| Receptors, Virus | 1 | 2005 | 83 | 0.010 |
Why?
| Polymorphism, Single-Stranded Conformational | 1 | 2004 | 28 | 0.010 |
Why?
| Seroepidemiologic Studies | 1 | 2005 | 156 | 0.010 |
Why?
| Immunohistochemistry | 1 | 2009 | 1669 | 0.010 |
Why?
| Antigens, Dermatophagoides | 1 | 2004 | 10 | 0.010 |
Why?
| U937 Cells | 1 | 2004 | 23 | 0.010 |
Why?
| Chromosomes, Human, Pair 20 | 1 | 2004 | 16 | 0.010 |
Why?
| NIH 3T3 Cells | 1 | 2004 | 141 | 0.010 |
Why?
| Treatment Outcome | 1 | 2018 | 10163 | 0.010 |
Why?
| Gene Deletion | 1 | 2006 | 372 | 0.010 |
Why?
| Germany | 1 | 2004 | 99 | 0.010 |
Why?
| Receptor, Anaphylatoxin C5a | 1 | 2004 | 30 | 0.010 |
Why?
| 3' Untranslated Regions | 1 | 2004 | 136 | 0.010 |
Why?
| Hyperglycemia | 1 | 2007 | 325 | 0.010 |
Why?
| Aquaporins | 1 | 2001 | 8 | 0.010 |
Why?
| Chimera | 1 | 2001 | 59 | 0.010 |
Why?
| Osmosis | 1 | 2001 | 17 | 0.010 |
Why?
| Crosses, Genetic | 1 | 2001 | 141 | 0.010 |
Why?
| Optics and Photonics | 1 | 2001 | 41 | 0.010 |
Why?
| Permeability | 1 | 2001 | 156 | 0.010 |
Why?
| Western Australia | 1 | 2001 | 6 | 0.010 |
Why?
| Lasers | 1 | 2001 | 132 | 0.010 |
Why?
| HIV-2 | 1 | 2000 | 18 | 0.010 |
Why?
| Cost Control | 1 | 2000 | 38 | 0.010 |
Why?
| Herpesvirus 6, Human | 1 | 2000 | 13 | 0.010 |
Why?
| Toxoplasma | 1 | 2000 | 39 | 0.010 |
Why?
| Cytomegalovirus | 1 | 2000 | 153 | 0.010 |
Why?
| Herpesvirus 4, Human | 1 | 2000 | 151 | 0.010 |
Why?
| Molecular Sequence Data | 1 | 2004 | 2818 | 0.010 |
Why?
| Expert Testimony | 1 | 1999 | 36 | 0.010 |
Why?
| Immunoglobulin M | 1 | 2000 | 268 | 0.010 |
Why?
| Observer Variation | 1 | 1999 | 315 | 0.010 |
Why?
| Lymphocytes | 1 | 2000 | 366 | 0.010 |
Why?
| Water | 1 | 2001 | 444 | 0.010 |
Why?
| Eosinophilia | 1 | 1999 | 205 | 0.010 |
Why?
| HIV-1 | 1 | 2000 | 840 | 0.010 |
Why?
| Physicians | 1 | 1999 | 860 | 0.010 |
Why?
|
|
Mathias's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|